Model Details

Patient Information for Model: TCH-AML002

Patient Information
Clinical Timeline


Clinical Information at Collection
Clinical Biomarkers/Mutations

Model Information for Model: TCH-AML002

Model Details
Mutations
There are no omics data for this model.

CNV


Metastasis Information for Model: TCH-AML002
 
Patient
PDX
Central Nervous System
Gingiva
Liver
Orbital chloroma
Skin
Spleen
Testis

Patient Treatment Information for Model: TCH-AML002

Event IdTreatmentTreatment SettingAge at StartAge at EndDurationClinical ResponseMeasurable Residual Disease
10Cytarabine/IdarubicinDe Novo20.060.0UnknownInduction Failure
20Cytarabine/FludarabineRefractory20.250.0UnknownResidual Disease
30clo/topotecan/vinorelbine/thiotepaRefractory20.370.0UnknownResidual Disease
40azacitidine/venetoclaxRefractory20.540.0Unknown
50venetoclaxRefractory20.660.0UnknownRemission.16%
70decitabine/venetoclax then DLIRelapse21.30.0UnknownRelapse14%
80decitabine/venetoclax then DLIRelapse21.40.0UnknownRelapse4%












Timeout
Your session is about to expire. Click 'Stay Connected' to continue the session.